| Suboptimal aminoglycoside dosing in critically ill patients RS Rea, B Capitano, R Bies, KL Bigos, R Smith, H Lee Therapeutic drug monitoring 30 (6), 674-681, 2008 | 161 | 2008 |
| Postmarketing drug dosage changes of 499 FDA‐approved new molecular entities, 1980–1999 J Cross, H Lee, A Westelinck, J Nelson, C Grudzinskas, C Peck Pharmacoepidemiology and drug safety 11 (6), 439-446, 2002 | 161 | 2002 |
| Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis H Lee, HC Kimko, M Rogge, D Wang, I Nestorov, CC Peck Clinical Pharmacology & Therapeutics 73 (4), 348-365, 2003 | 141 | 2003 |
| Population pharmacokinetics of golimumab, an anti‐tumor necrosis factor‐α human monoclonal antibody, in patients with psoriatic arthritis Z Xu, T Vu, H Lee, C Hu, J Ling, H Yan, D Baker, A Beutler, C Pendley, ... The Journal of Clinical Pharmacology 49 (9), 1056-1070, 2009 | 112 | 2009 |
| Is extrapolation of the safety and efficacy data in one indication to another appropriate for biosimilars? H Lee The AAPS journal 16 (1), 22-26, 2014 | 111 | 2014 |
| A Pharmacokinetic‐pharmacodynamic Model for the Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100 NA Lack, B Green, DC Dale, GB Calandra, H Lee, RT MacFarland, ... Clinical Pharmacology & Therapeutics 77 (5), 427-436, 2005 | 97 | 2005 |
| Population pharmacokinetic analysis and simulation of the time‐concentration profile of etanercept in pediatric patients with juvenile rheumatoid arthritis DS Yim, H Zhou, M Buckwalter, I Nestorov, CC Peck, H Lee The Journal of Clinical Pharmacology 45 (3), 246-256, 2005 | 97 | 2005 |
| The current status of drug repositioning and vaccine developments for the COVID-19 pandemic JH Won, H Lee International Journal of Molecular Sciences 21 (24), 9775, 2020 | 56 | 2020 |
| Simulation of correlated continuous and categorical variables using a single multivariate distribution SJ Tannenbaum, NHG Holford, H Lee, CC Peck, DR Mould Journal of pharmacokinetics and pharmacodynamics 33, 773-794, 2006 | 56 | 2006 |
| Population pharmacokinetics of golimumab in patients with ankylosing spondylitis: impact of body weight and immunogenicity. ZH Xu, H Lee, T Vu, C Hu, H Yan, D Baker, B Hsu, C Pendley, C Wagner, ... International journal of clinical pharmacology and therapeutics 48 (9), 596-607, 2010 | 53 | 2010 |
| Clonidine clearance matures rapidly during the early postnatal period: a population pharmacokinetic analysis in newborns with neonatal abstinence syndrome HG Xie, YJ Cao, EB Gauda, AG Agthe, CW Hendrix, H Lee The Journal of Clinical Pharmacology 51 (4), 502-511, 2011 | 51 | 2011 |
| Effects of proton pump inhibitors on metformin pharmacokinetics and pharmacodynamics AH Kim, I Chung, SH Yoon, KS Yu, KS Lim, JY Cho, H Lee, IJ Jang, ... Drug Metabolism and Disposition 42 (7), 1174-1179, 2014 | 46 | 2014 |
| Safety, tolerability, pharmacokinetics, and pharmacodynamics of fimasartan following single and repeated oral administration in the fasted and fed states in healthy subjects YH Chi, H Lee, SH Paik, JH Lee, BW Yoo, JH Kim, HK Tan, SL Kim American Journal of Cardiovascular Drugs 11, 335-346, 2011 | 45 | 2011 |
| Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome JH Lee, S Faderl, JM Pagel, CW Jung, SS Yoon, AD Pardanani, ... Blood advances 4 (9), 2032-2043, 2020 | 42 | 2020 |
| A thorough QT study to evaluate the QTc prolongation potential of two neuropsychiatric drugs, quetiapine and escitalopram, in healthy volunteers A Kim, KS Lim, H Lee, H Chung, SH Yoon, KS Yu, JY Cho, IJ Jang, ... International clinical psychopharmacology 31 (4), 210-217, 2016 | 41 | 2016 |
| Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies: a systematic review of papers published between 1990 and 2013 HY Suh, CC Peck, KS Yu, H Lee Drug design, development and therapy, 4005-4016, 2016 | 36 | 2016 |
| Effects of HM30181, a P‐glycoprotein inhibitor, on the pharmacokinetics and pharmacodynamics of loperamide in healthy volunteers TE Kim, H Lee, KS Lim, SH Lee, SH Yoon, KM Park, H Han, SG Shin, ... British journal of clinical pharmacology 78 (3), 556-564, 2014 | 36 | 2014 |
| What does it take to make model-informed precision dosing common practice? Report from the 1st Asian symposium on precision dosing TM Polasek, A Rostami-Hodjegan, DS Yim, M Jamei, H Lee, H Kimko, ... The AAPS journal 21, 1-9, 2019 | 35 | 2019 |
| Once‐daily enoxaparin in pediatric thromboembolism: a dose finding and pharmacodynamics/pharmacokinetics study1 SH O’BRIEN, H Lee, AK Ritchey Journal of Thrombosis and Haemostasis 5 (9), 1985-1987, 2007 | 35 | 2007 |
| Adherence and persistence rates of major antidiabetic medications: a review DSU Lee, H Lee Diabetology & Metabolic Syndrome 14 (1), 12, 2022 | 34 | 2022 |
